Published in PLoS One on September 22, 2016
Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data. Med Care (2005) 30.41
Variable selection for propensity score models. Am J Epidemiol (2006) 10.68
Excess mortality of schizophrenia. A meta-analysis. Br J Psychiatry (1997) 4.07
Twenty-five year mortality of a community cohort with schizophrenia. Br J Psychiatry (2010) 2.72
Cardiac arrest and ventricular arrhythmia in patients taking antipsychotic drugs: cohort study using administrative data. BMJ (2002) 2.46
Depression, psychotropic medication, and risk of myocardial infarction. Prospective data from the Baltimore ECA follow-up. Circulation (1996) 2.27
Medical comorbidity in schizophrenia. Med J Aust (2003) 2.20
Fatal myocardial infarction and use of psychotropic drugs in young women. Lancet (1992) 2.16
Psychotropic medications and the risk of sudden cardiac death during an acute coronary event. Eur Heart J (2011) 1.99
Association of cerebrovascular events with antidepressant use: a case-crossover study. Am J Psychiatry (2011) 1.89
Total first-year costs of acute coronary syndrome in a managed care setting. J Manag Care Pharm (2005) 1.84
Acute coronary syndrome national statistics: challenges in definitions. Am Heart J (2005) 1.74
Second-generation antipsychotic medications and risk of pneumonia in schizophrenia. Schizophr Bull (2012) 1.62
Cardiovascular disease in patients with schizophrenia in Saskatchewan, Canada. J Clin Psychiatry (2004) 1.48
Prevalence of cardiovascular risk factors and disease in people with schizophrenia: a population-based study. Schizophr Res (2010) 1.32
Serious cardiovascular events and mortality among patients with schizophrenia. J Nerv Ment Dis (2004) 1.32
Metabolic syndrome and the risk of coronary heart disease in 367 patients treated with second-generation antipsychotic drugs. J Clin Psychiatry (2006) 1.14
New Generation Antipsychotic Drugs and QTc Interval Prolongation. Prim Care Companion J Clin Psychiatry (2003) 1.13
Treatment of schizophrenia with long-acting fluphenazine, haloperidol, or risperidone. Schizophr Bull (2007) 1.05
Use of psychotropic drugs and risk of myocardial infarction: a case-control study in Finnish farmers. Int J Epidemiol (1996) 1.02
Associations between health risk behaviors and symptoms of schizophrenia and bipolar disorder: a systematic review. Gen Hosp Psychiatry (2012) 0.96
Aripiprazole acts as a selective dopamine D2 receptor partial agonist. Expert Opin Investig Drugs (2007) 0.95
A pharmacoeconomic analysis of atypical antipsychotics and haloperidol in first-episode schizophrenic patients in taiwan. J Clin Psychopharmacol (2008) 0.90
The association between antipsychotic agents and the risk of myocardial infarction: a systematic review. Br J Clin Pharmacol (2011) 0.89
Antipsychotics and risk of first-time hospitalization for myocardial infarction: a population-based case-control study. J Intern Med (2006) 0.87
Predictors of high-cost managed care patients with acute coronary syndrome. Curr Med Res Opin (2005) 0.87
Outcomes of hospitalized patients with non-acute coronary syndrome and elevated cardiac troponin level. Am J Med (2011) 0.86
Antipsychotic drugs, mood stabilizers, and risk of pneumonia in bipolar disorder: a nationwide case-control study. J Clin Psychiatry (2013) 0.83
Metabolic syndrome with different antipsychotics: a multicentre cross-sectional study. Psychopharmacol Bull (2010) 0.81
Impact of dyspnea on medical utilization and affiliated costs in patients with acute coronary syndrome. Hosp Pract (1995) (2011) 0.80
Risk of acute coronary syndrome in elderly users of antipsychotic drugs: a nested case-control study. Heart (2012) 0.79
Cardiac complications associated with short-term mortality in schizophrenia patients hospitalized for pneumonia: a nationwide case-control study. PLoS One (2013) 0.77